Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses?
- PMID: 17616438
- DOI: 10.1016/j.coph.2007.05.003
Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses?
Abstract
Despite the accepted knowledge that the activity of antibiotics depends on the unbound concentration at the site of infection, current pharmacodynamic analysis mostly relies on published total blood concentrations. Such concentrations do not necessarily correlate with concentrations at the site of infection. Methodological problems and separation of bound and unbound fractions, however, limit the applicability of most measured 'tissue concentrations' as adequate pharmacokinetic input into pharmacodynamic analyses. Recently, research on using free blood concentrations as surrogate concentrations has received more attention and may be useful for infection sites such as soft tissue infections. Although our understanding of antibiotic pharmacodynamics in tissues has become much more advanced, we are still lacking appropriate and accurate pharmacokinetic data derived from the site of infection.
Similar articles
-
[Monitoring of antibiotic treatment of patient with a severe bacterial infection].Ann Fr Anesth Reanim. 2004 Jul;23(7):704-13. doi: 10.1016/j.annfar.2004.03.014. Ann Fr Anesth Reanim. 2004. PMID: 15324959 French.
-
The management of bacterial infections of the upper respiratory tract in children: pharyngitis and otitis media.Manag Care Interface. 2000 Apr;13(4):83-8. Manag Care Interface. 2000. PMID: 11066289
-
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore.Clin Infect Dis. 2007 Jan 1;44(1):79-86. doi: 10.1086/510079. Epub 2006 Nov 27. Clin Infect Dis. 2007. PMID: 17143821
-
Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics.Pharmacotherapy. 2005 Dec;25(12 Pt 2):150S-158S. doi: 10.1592/phco.2005.25.12part2.150S. Pharmacotherapy. 2005. PMID: 16305286 Review.
-
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.Int J Antimicrob Agents. 2009 Dec;34(6):506-15. doi: 10.1016/j.ijantimicag.2009.08.013. Epub 2009 Oct 13. Int J Antimicrob Agents. 2009. PMID: 19828298 Review.
Cited by
-
Clinical Breakpoint of Apramycin to Swine Salmonella and Its Effect on Ileum Flora.Int J Mol Sci. 2022 Jan 26;23(3):1424. doi: 10.3390/ijms23031424. Int J Mol Sci. 2022. PMID: 35163350 Free PMC article.
-
Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity.Drug Deliv. 2018 Nov;25(1):1585-1594. doi: 10.1080/10717544.2018.1492046. Drug Deliv. 2018. PMID: 30044149 Free PMC article.
-
Comparative Plasma Pharmacokinetics of Ceftriaxone and Ertapenem in Normoalbuminemia, Hypoalbuminemia, and Albumin Replacement in a Sheep Model.Antimicrob Agents Chemother. 2020 Jun 23;64(7):e02584-19. doi: 10.1128/AAC.02584-19. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32366707 Free PMC article.
-
Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or Tulathromycin.PLoS One. 2016 Feb 12;11(2):e0149100. doi: 10.1371/journal.pone.0149100. eCollection 2016. PLoS One. 2016. PMID: 26872361 Free PMC article.
-
Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations.Br J Clin Pharmacol. 2012 Apr;73(4):588-96. doi: 10.1111/j.1365-2125.2011.04117.x. Br J Clin Pharmacol. 2012. PMID: 21988468 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical